Delavirdine is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI).

Delavirdine mesylate is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI).

Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) with anti-HIV effect.

Etravirine is an inhibitor of non-nucleoside reverse transcriptase used to treat HIV.

Dapivirine is an inhibitor of HIV reverse transcriptase with IC50 of 24 nM which is effective for many types of viruses.

Efavirenz is an inhibitor of wild-type HIV-1 reverse transcriptase with Ki of 2.93 nM and the IC95 of its replicative spread is 1.5 nM in cell culture.

Nevirapine is an inhibitor of reverse transcriptase which is used in combination with nucleoside analogues to treat HIV-1 infection.

Lersivirine is a next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI, IC50=119 nM) with a unique resistance profile that exhibits potent antiretroviral activity against wild-type human immunodeficiency virus and clinically relevant NNRTI-resistant strains.

Elsulfavirine 是一种 HIV-1 逆转录酶抑制剂，也是一种新型抗 HIV 活性分子。Elsulfavirine 主要用于 HIV 感染的治疗研究。

Dexelvucitabine is a nucleoside reverse transcriptase inhibitor potentially for the treatment of HIV infection.

Etravirine D4 is the deuterium labeled Etravirine, which is a NNRTI used for the treatment of HIV.

Tomeglovir, a non-nucleoside antiviral, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs.

MK-4965 is a nonnucleoside reverse transcriptase inhibitor with anti-viral activity. MK-4965 possesses the desired properties for further development as an NNRTI for the treatment of HIV-1 infection.

Lamivudine is a nucleoside reverse transcriptase inhibitors (NRTIs)， which can inhibit HIV reverse transcriptase 1/2 and also the reverse transcriptase of hepatitis B virus.